Stroke Trial, Recruiting (NCT00084292)

Stroke Trial, Recruiting NCT00084292 Sponsor: The Hospital for Sick Children Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT00084292 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children from birth to 18 years of age who have been diagnosed with a stroke after January 1, 2003, at one of the participating trial sites
Children diagnosed with arterial ischemic stroke (a stroke caused by a blocked artery in the brain)
Children diagnosed with cerebral sinovenous thrombosis (a blood clot in the veins of the brain)
Children diagnosed with both of the above stroke types together
Children diagnosed with a presumed perinatal ischemic stroke (a stroke that is thought to have occurred around the time of birth)
Children diagnosed with a bleeding-type stroke (hemorrhagic stroke)
Children who have been diagnosed with conditions that put them at high risk of stroke, such as problems with blood vessels in the brain, sickle cell disease-related brain damage, or abnormal tangles of blood vessels in the brain (arteriovenous malformations)

Who may not be able to join:

Premature babies (born early) who have been diagnosed with an arterial ischemic stroke
Premature babies (born early) who have been diagnosed with a presumed perinatal ischemic stroke
Children who have had a transient ischemic attack (a brief, temporary stroke-like episode sometimes called a "mini-stroke")
Children whose brain bleeding was caused by a physical injury or trauma
Children or families who do not agree to give consent to take part in the registry

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nomazulu Dlamini, MD, The Hospital for Sick Children

Phone: 416-813-7654

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00084292

Sponsor: The Hospital for Sick Children

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: 416-813-7654

More information: https://clinicaltrials.gov/study/NCT00084292

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children from birth to 18 years of age who have been diagnosed with a stroke after January 1, 2003, at one of the participating trial sites
Children diagnosed with arterial ischemic stroke (a stroke caused by a blocked artery in the brain)
Children diagnosed with cerebral sinovenous thrombosis (a blood clot in the veins of the brain)
Children diagnosed with both of the above stroke types together
Children diagnosed with a presumed perinatal ischemic stroke (a stroke that is thought to have occurred around the time of birth)
Children diagnosed with a bleeding-type stroke (hemorrhagic stroke)
Children who have been diagnosed with conditions that put them at high risk of stroke, such as problems with blood vessels in the brain, sickle cell disease-related brain damage, or abnormal tangles of blood vessels in the brain (arteriovenous malformations)

Who may not be able to join:

Premature babies (born early) who have been diagnosed with an arterial ischemic stroke
Premature babies (born early) who have been diagnosed with a presumed perinatal ischemic stroke
Children who have had a transient ischemic attack (a brief, temporary stroke-like episode sometimes called a "mini-stroke")
Children whose brain bleeding was caused by a physical injury or trauma
Children or families who do not agree to give consent to take part in the registry

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Hospital for Sick Children

Registry

ClinicalTrials.gov

Start date

1 January 2003

Est. completion

1 December 2030

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change from Pediatric Stroke Outcome Measure at 3 months.; Recovery and Recurrence Questionnaire; King's Outcome Scale for Childhood Head Injury (KOSCHI); modified Rankin Scale (mRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov